You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

~ Buy the XENLETA (lefamulin acetate) Drug Profile, 2024 PDF Report in the Report Store ~

Bulk Pharmaceutical API Sources for XENLETA


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for XENLETA

Vendor Vendor Homepage Vendor Sku API Url
DC Chemicals ⤷  Sign Up DC8172 ⤷  Sign Up
MuseChem ⤷  Sign Up I007398 ⤷  Sign Up
001Chemical ⤷  Sign Up DY34218 ⤷  Sign Up
Lan Pharmatech ⤷  Sign Up LAN-B68209 ⤷  Sign Up
THE BioTek ⤷  Sign Up bt-272945 ⤷  Sign Up
Smolecule ⤷  Sign Up S532713 ⤷  Sign Up
>Vendor >Vendor Homepage >Vendor Sku >API Url

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.